Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology - 1 Jun 2012

Saadah Omar I, Sindi Haifa H, Bin-Talib Yagoub, Al-Harthi Sameer, Al-Mughales Jamil

Abstract excerpt

BACKGROUND AND STUDY AIMS: Childhood acquired chronic hepatitis B is associated with a significant lifetime risk of developing cirrhosis or hepatocellular carcinoma. Our objective in this study was to report retrospectively the response to treatment with Entecavir in 8 children with chronic hepatitis B followed at the King Abdulaziz University Hospital, Jeddah, Saudi Arabia. PATIENTS AND METHODS: This study is an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Viral

Share to Guanine

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Treatment Outcome

Source

Identifiers

PMID: 22980589
DOI: 10.1016/j.ajg.2012.04.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.PMID 22980589Read ↗

A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B.Semantic proximity Read ↗

Sequential therapy with entecavir and pegylated interferon in a cohort of young patients affected by chronic hepatitis B.Semantic proximity Read ↗

Treatment strategies according to genotype for chronic hepatitis B in childrenSemantic proximity Read ↗

Use of entecavir for the treatment of complex forms of hepatitis B.Semantic proximity Read ↗

Management of hepatitis C virus infection in childhood.Semantic proximity Read ↗

Treatment of chronic hepatitis B: Evolution over two decadesSemantic proximity Read ↗

Treatment of hepatitis C in children and adolescents: how far have we reached?Semantic proximity Read ↗

Meeting the WHO hepatitis C virus elimination goal: Review of treatment in paediatrics.Semantic proximity Read ↗

Management of Hepatitis C in Children - A New Paradigm.Semantic proximity Read ↗

[Entecavir].Semantic proximity Read ↗

Burden of pediatric hepatitis C.Semantic proximity Read ↗

Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.